918²«ÌìÌÃ

½Ó´ý»á¼û918²«ÌìÌùٷ½ÍøÕ¾£¡

ÎÄÏ××ÊÁÏ

ÁªÏµ918²«ÌìÌÃ

918²«ÌìÌÃ

µç»°£º0570£­8788056

´«Õ棺0570£­8788381

ÓÊÏ䣺zjgykp@163.com

µØµã£ºÕã½­Ê¡áéÖÝÊж«¸Û¾­¼Ã¿ª·¢Çø

¶«¸Û4·2ºÅ

ÄúËùÔÚµÄÄ¿½ñλÖãºÊ×Ò³ > ÎÄÏ××ÊÁÏ > Ö×ÁöÀàÎÄÏ×
  • µÍ·Ö×Ó¸ÌéÙ¹û½ºÔÚÖ×ÁöÖÎÁÆÖеÄÑо¿½øÕ¹
  • Ðû²¼Ê±¼ä£º 2019/4/24¡¡µã»÷´ÎÊý£º3856¡¡
  •  µÍ ·Ö ×Ó ¸Ì éÙ ¹û ½º ÔÚ Ö× Áö ÖÎ ÁÆ ÖÐ µÄ ÑÐ ¾¿ ½ø Õ¹
    Íô·å£¬Áõº£Ó¥!
    ¹ãÖÝҽѧԺÁ¥ÊôÖ×ÁöҽԺ賦Íâ¿Æ( ¹ãÖÝ 510095  )

      ÊÖÊõÓë·Å¡¢»¯ÁƽáºÏµÄ×ÛºÏÖÎÁÆÊÇÄ¿Ç°¶ñÐÔÖ×ÁöÖÎÁƵıê׼ģʽ¡£¹Å°å»¯ÁÆÒ©ÎïµÄȱµãÔÚÓÚȱ·¦¶ÔÕý³£Ï¸°ûÓëÖ×Áöϸ°ûµÄÑ¡ÔñÐÔ£¬Ò©Îï²»Á¼·´Ó¦ÏÞÖÆÁËÆäÖÎÁÆÇ¿¶ÈºÍƵÂÊ£¬ÓÖ±£´æÄÍÒ©ÎÊÌ⣬¹Êʹ´ó´ó¶¼»¼ÕßµÄÖÎÁÆÄÑÒÔΪ¼Ì¡£ÓëÖ®Ïà±È£¬Êµ¼ùÒÑÖ¤Ã÷·Ö×Ó°ÐÏòÖÎÁƾßÓиßÑ¡ÔñÐÔ¡¢µÍ¶¾ÐԺ͸ßÖÎÁÆÖ¸Êý£¬¿Éºã¾ÃÓÃÒ©¡£ËüÒÔÖ×Áöϸ°ûµÄijЩÌØÊâ·Ö×ÓΪ×÷Óðе㣬ͨ¹ýʹÓÃС·Ö×Ó»¯ºÏÎï¡¢µ¥¿Ë¡¿¹Ìå¡¢¶àëĵÈÎïÖÊ£¬ÌØÒìÐÔ¸ÉÔ¤µ÷ÀíÖ×Áöϸ°ûÉúÎïѧÐÐΪµÄÐźÅͨ·£¬´Ó¶øµÖ´ïÒÖÖÆ Ö×ÁöÉú³¤µÄÄ¿µÄ¡£ÔÚÌåÏÖ³ö¸üÇ¿¿¹Ö×Áö»îÐÔµÄͬʱ£¬Òà¼õÉÙ¶ÔÕý³£Ï¸°ûµÄ¶¾¸±×÷Óá£ÕâÖÖÓеķÅʸµÄÖÎÁÆÒªÁìΪÖ×ÁöÖÎÁÆÖ¸Ã÷ÁËеÄÆ«Ïò¡£Ñ°ÕÒеÄ×÷ÓðеãºÍÕë¶ÔÕâÖְеãµÄ¸ß Ч¡¢ÌØÒìÐÔ»¯ºÏÎïÊÇÄ¿Ç°¿¹°©ÊÂÇéÕßµÄÆÈÇпÊÍûºÍÊܵ½¹ã·ºÖØÊÓµÄÑо¿¿ÎÌâ¡£µÍ·Ö×Ó¸ÌéÙ¹û½º(low£­molecular£­weight-citruspectin£¬LCP)ÊÇÒ»ÖÖ´Ó¸ÌéÙÀàË®¹ûµÄ¹ûƤ¼°¹û½¬ÖÐÌáÈ¡³öµÄË®ÈÜÐÔ¶àÌÇÀ໯ºÏÎÔÚ¾­¹ý¸ßpH¼°¸ßδ¦Àíºó£¬ÄÜÓë¶ñÐÔ±íÐ͵Äϸ°ûÇ׺Í𤸽£¬ÌØÒìÐÔɱÉ˲¢Çå³ýÍ»±äϸ°û£Û1£Ý¡£Ëü¿ÉÒÔ×÷ΪÌåÄÚ°ëÈéÌÇÄý¼¯ËØ£­3(Galectin£­3£¬Gal£­3)ÅäÌåµÄ¾ºÕùÐÔÒÖÖƼÁ£¬¹Ø±ÕÖ×Áöϸ°ûÍâòµÄGalectin£­3 λµã£¬×èÖ¹Ö×Áöϸ°ûµÄÐγÉÓëÉú³¤£Û1£Ý¡£¶øËüËùÕë¶ÔµÄGalec-tin£­3±»³ÆΪ¡°Ö×ÁöÏà¹ØÂѰס±£¬¹ã·ºÂþÑÜÓÚÕý³£Ï¸°û¼°Ö×Áöϸ°û£¬¼ÓÈëµ÷Àíϸ°ûÉú³¤ÓëÆÊÎö£¬ËüÏÕЩÓëÖ×ÁöÐγɡ¢Éú³¤ÓëתÒƵÄÈ«Àú³ÌÃÜÇÐÏà¹Ø£Û2£Ý¡£

    1.LCPÓëʧ³²µòÍö(anoikis)

    Ö×Áöϸ°ûµÄתÒÆ£¬Ê×ÏȱØÐë´©¹ý»ùµ×Ĥ(basementmem-brane£¬BM)ºÍϸ°ûÍâ»ùÖÊ(extracellularmatrix£¬ECM)£¬ÍÑÀëÔ­·¢²¿Î»½øÈëѪҺ¡£ÔÚÕâÒ»Àú³ÌÖУ¬Ö×Áöϸ°û±ØÐëÃæ¶ÔÒòʧȥÓë»ùÖÊ𤸽¡¢Ãª¶¨¶ø±¬·¢µÄʧ³²µòÍö£¬²¢ÇÒÔÚËæѪתÔ˵ÄÀú³ÌÖмá³Ö´æ»î¡£Ñо¿ÏÔʾ£¬Galectin£­3ÊÇÖ×Áöϸ°û¶Ô¿¹Ê§³²µòÍöµÄÒªº¦ÒÖÖÆÂÑ°×£Û3£Ý¡£ËüÖ÷Ҫͨ¹ýµ÷ÀíÖÜÆÚÂÑ°×¼°ÆäÒÖÖÆÒò×ӵıí´ï´Ùʹϸ°û¿ìËÙͨ¹ý¶ÔµòÍö´Ì¼¤Ãô¸ÐµÄG1ÔçÆÚ£¬Ê¹Ï¸°ûÖÜÆÚÍ£ÖÍÔÚ¶Ôʧ³²µòÍö²»Ãô¸ÐµÄG1ºóÆÚ¡£

    HSIEHµÈ£Û4£ÝÑо¿ÏÔʾ£¬LCPÓ°ÏìÈËÇ°ÁÐÏÙ°©Ï¸°ûJAC£­1µÄϸ°ûÖÜÆÚ£¬Ïµ÷Æäcyclin£­B¼°cdc2£¬Ê¹Ï¸°û»ýÀÛÓÚG2/M ÆÚ£¬ÓÕµ¼±¬·¢µòÍö¡£Ö¤ÊµLCP¿ÉÃ÷ÏÔÒÖÖÆGalectin£­3¶Ôʧ³²µòÍöµÄ¶Ô¿¹×÷ÓÃËæºó£¬ÔÚÈéÏÙÉÏƤϸ°û°©Ñо¿ÖлñµÃÀàËƵı¨µÀ£Û5£Ý¡£µ«Ä¿Ç°ÉÐÎÞLCPÖ±½Ó×÷ÓÃÓÚϸ°ûʧ³²µòÍöµÄÖ¤¾Ý¡£

    2.LCPÓëÖ×Áöϸ°ûÔÚתÒÆ°ÐÆ÷¹ÙµÄ¡°×Å´²¡±

    Ö×Áöϸ°ûÀÖ³ÉÌÓÒݺó£¬Í¨¹ýÑ­»·µÖ´ïÔ¶´¦°ÐÆ÷¹Ù£¬ÔÚÆäÂö¹ÜϵͳÖÐÍ£Áô¡£ÔÚGalectin£­3µÄ×ÊÖúÏ£¬×ªÒƵÄÖ×Áöϸ°ûÓëѪ¹ÜÄÚƤϸ°û𤸽¡°×Å´²¡±¡£ÔÚÕâÀGalectin£­3ÓëÖ×ÁöÏà¹ØT¿¹Ô­(thomson£­friederreichglyoantigen)Ï໥×÷Óã¬ÏÈÊǽ鵼Ö×Áöϸ°û¶¨Î»ÓÚѪ¹ÜÄÚƤϸ°û£¬½ô½Ó×ÅÓÖ´ÙʹÖ×Áöϸ°ûÖ®¼äͬÐ;ۼ¯ÓÚ¡°×Å´²µã¡±£Û3£¬6£Ý¡£LCP¾ßÓÐÇ¿´óµÄ¿¹ð¤¸½ÌØÐÔ£¬ÄÜÓÐЧ×ÌÈÅ°©Ï¸°ûÖ®¼äµÄͬÐ;ۼ¯¼°ÆäÓëѪ¹ÜÄÚƤϸ°ûÏà𤸽¡£LehrµÈ£Û7£ÝÔÚÌåÍâʵÑéÖжÔ11ÖÖ¿¹ð¤¸½Ð¡·Ö×Ó½øÐÐÁ˲âÊÔ£¬Ö¤ÊµLCP×îÄܹ»×è¶ÏÇ°ÁÐÏÙ°©Ï¸°ûÓë¹ÇËèÄÚƤϸ°ûÏà𤸽¡£ÌåÄÚÊÔÑéÖУ¬LCPÒÖÖÆÈéÏÙ°©Ï¸°ûºÍÇ°ÁÐÏÙ°©Ï¸°ûÔڷΡ¢¹Ç×éÖ¯ÖÐÐγÉתÒÆÁöµÄÓÐЧÂÊ´óÓÚ90%£Û7£Ý¡£ 

    3.LCPÓëÖ×Áöϸ°ûÇÖÏ®ÐÔ

    Ö×Áöϸ°û¡°×Å´²¡±ÓÚÔ¶´¦°ÐÆ÷¹Ùºó£¬Á¢¼´ÔÚ΢Ѫ¹ÜÄÚÔöÖ³£¬½ø¶ø´©Í¸Ñª¹Ü±Ú£¬ÇÖÈëʵÖÊÐγÉתÒÆÁö¡£ÔÚÕý³£Ï¸°ûÓëÖ×Áöϸ°ûÖ®¼ä£¬±£´æÓÉ»ùµ×ĤºÍϸ°ûÍâ»ùÖÊ×é³ÉµÄ¡°ÆÁÕÏ¡±£¬ºóÕßÖ÷ÒªÊÇһЩ½áµÞ×éÖ¯Éí·ÖµÄ»ìÏýÎ°üÀ¨½ºÔ­¡¢²ã𤵰 °×¡¢ÂѰ׶àÌǵÈÐí¶à·Ö×Ó¡£×ªÒƵÄÖ×Áöϸ°û±ØÐë¾­¹ýÓëϸ°ûÍâ»ùÖʼäµÄһϵÁз´Ó¦£¬²Å»ª¹»ÇÖÏ®Àֳɣ¬ÐγÉתÒÆÁö¡£Óб¨µÀÏÔʾ£¬¸ß±í´ïGal£­3µÄÇ°ÁÐÏÙ°©Ï¸°û±È²»±í´ïµÄ°©Ï¸°ûÇÖÏ®Á¦¸ßµÃ¶à£¬Ö¤Ã÷Gal£­3µÄ±í´ïÓëϸ°ûÇÖÏ®ÐÔÏà¹Ø£Û8£Ý¡£ÌåÍâʵÑéÖУ¬LCPÀÖ³ÉÒÖÖÆÁËÈËÈéÏÙ°©¼°¿ÚÇ»°©Ï¸°û´©¹ýÓÉ ÄÚƤϸ°û¹¹½¨µÄÈ˹¤»ùµ×ĤģÐÍ£¬²¢ÇÒÕâÖÖÒÖÖÆ×÷ÓóʼÁÁ¿ÒÀÀµÐÔ£Û9£Ý¡£½ñºóµÄ²î±ðϸ°ûÄ£ÐÍÖУ¬LCP¾ùÏÔʾ³öÒÖÖÆ°©Ï¸°ûÇÖÏ®Á¦µÄÄÜÁ¦£Û10£Ý¡£LCPµÄÕâÖÖ¼õµÍÖ×Áöϸ°ûÇÖÏ®µÄÄÜÁ¦£¬¼«¿ÉÄÜÓëÒÖÖÆGal£­3ÓйØ¡£

    4.LCPÓëÔçÆÚתÒƵĿË¡Êý

    Ëæ×ÅÖ×Áöϸ°ûÍ£ÁôÔÚÔ¶´¦Æ÷¹Ù²¢´©³öѪ¹Ü£¬ÆäÖеľø´ó¶à°©Ï¸°ûÃæÁÙ×ŵòÍö£¬Ö»Óв»µ½2%µÄϸ°û´æ»î£¬ÐγÉ΢ת ÒÆ¡£ÔçÆÚϸ°û¿Ë¡µÄ´æ»îÊÇÐγÉÓÐЧתÒƵÄÒªº¦¡£×÷ΪÖ×Áöϸ°ûµÄ± £»¤ÐÔ»úÖÆÖ®Ò»£¬Gal£­3ͨ¹ýÒÖÖÆϸ°ûµòÍö£¬Ôö¼ÓÔçÆÚ¿Ë¡µÄ´æ»îÊýÁ¿£Û8£Ý¡£×îÐÂÑо¿ÏÔʾ£¬LCPÄܹ»Ã÷ÏÔÓ°ÏìÌåÍâѪ¹ÜÈâÁöϸ°ûµÄ¿Ë¡ÐγÉ¡£ÕâÒ»»úÖÆÓ¦¸ÃÓë½µµÍGal£­3µÄ¿¹µòÍöÄÜÁ¦ÓйأÛ2£Ý¡£

    5.LCPÓëѪ¹ÜÉú³É

    ×Ô´ÓFolkman·¢Ã÷Ö×ÁöÉú³¤ÓëѪ¹ÜÐγÉÃÜÇÐÏà¹ØÒÔÀ´£¬ÐÂÉúѪ¹ÜÉú³ÉÄÜÁ¦±»ÈÏΪÊÇÖ×ÁöÇÖÏ®ÐԵıê¼Ç¡£Î¢×ªÒÆÉú³¤³ÉΪÁÙ´²×ªÒÆÁöÓÐÀµÓÚÐÂÉúѪ¹ÜµÄÉú³É¡£ÕâÊÇһϵÁÐϸ°ûºÍ·Ö×ÓÕýÏò¼°¸ºÏòµ÷ÀíµÄ×ۺϽá¹û¡£Gal£­3ÔÚÕâÒ»Àú³ÌÖÐÊÎÑÝÁ˼«ÆäÖØÒªµÄ½ÇÉ«£¬ËüÍâòµÄÌÇʶ±ð½á¹¹ÓòÄÜÓëϸ°ûÍâòµÄÊÜÌå½áºÏÔö½øëϸѪ¹ÜÉú³É£Û11£­12£Ý¡£LCPÓ°ÏìÈËÄÚƤϸ°û¶ÔGal£­3µÄÇ÷»¯ÐÔ£¬½µµÍѪ¹ÜÉú³ÉÄÜÁ¦£¬²¢ÇÒÕâÖÖÒÖÖÆ ×÷ÓóʼÁÁ¿ÒÀÀµÐÔ¡£ÌåÍâʵÑéÓèÒÔŨ¶È0£®1%µÄLCP¼´ÄÜÍêÈ«ÒÖÖÆѪ¹ÜÉú³É£Û13£Ý¡£ÌåÄÚÊÔÑéÖУ¬¿Ú·þLCPÄÜ×è¶Ï¶àÖÖÖ×Áöϸ°ûµÄÉú³ÉºÍתÒÆ£Û14£Ý¡£±¾¿ÎÌâ×éÇ°ÆÚÊÔÑéÒàÒÑ֤ʵ£¬ÔÚСÊóµÄ½á³¦°©Ä£ÐÍÖУ¬¿Ú·þLCPÄܹ»¼õÉÙתÒÆÔîµÄѪ¹ÜÉú³É£¬ÓÐЧÒÖÖƸÎתÒÆ£Û14£Ý¡£

    6.LCP¶ÔµòÍöµÄÓÕµ¼×÷ÓÃ

    Gal£­3ÓëBcl£­2ÓÐÃ÷ÏÔµÄÐòÁÐÏàËÆÐÔ¡£Ëüº¬ÓÐ2¸ö¿¹µòÍöµÄÐòÁУ¬ÆäÒ»¿ÉÓëBcl£­2½áºÏ±¬·¢¿¹µòÍö×÷ÓÃ;ÁíÒ»¸öÊÇSer6λµã£¬¸ÃλµãΪCKIµÄÁ×Ëữλµã(´ËµãÍ»±äºó£¬Gal£­3ʧȥ¿¹µòÍöÄÜÁ¦)£Û14£Ý¡£ÓÐÑо¿±êÃ÷£¬°ûºËGal£­3Á×Ëữ²¢×ªÒÆÖÁϸ°û½¬ÊÇÆä·¢»Ó¿¹µòÍö¹¦Ð§µÄÒªº¦°ì·¨£Û15£Ý¡£ÔÚתȾGal£­3ÔØÌåºóµÄÇ°ÁÐÏÙ°©LNCaPϸ°ûÖУ¬Ë³²¬ÓÕµ¼Ï¸°ûºË Gal£­3Á×Ëữ²¢ÓÉתÒÆϸ°û½¬»òºËÖÜĤ£¬°û½¬ÖÐÁ×ËữGal£­3 ½øÒ»²½ÓÕµ¼BadÂÑ°×Á×Ëữ£¬µ÷ÀíBcl£­2Îȶ¨ÏßÁ£ÌåĤµç 룬ÒÖÖÆϸ°ûÉ«ËØCÊͷźÍcaspase£­3¼¤»î£¬´Ó¶øÆ𵽿¹µòÍö×÷Óá£×ªÈ¾ÁËÒ°ÉúÐÍGal£­3ÔØÌåµÄÈéÏÙ°©BT£­549ϸ°ûÖУ¬¾­Ë³²¬ÖÎÁƺó£¬ÓÉ°ûºËתÔËÖÁ°û½¬µÄÁ×ËữGal£­3£¬Äܼ¤»îϸ°ûÍâÐźŵ÷Àí¼¤Ã¸(ERK)ºÍJun°±»ùÄ©¶Ë¼¤Ã¸(JNK)£¬ºóÁ½Õß¼¤»î´ÙÆÆÁÑÔ­»î»¯ÂÑ°×¼¤Ã¸(MAPK);¾¶¶øÒÖÖƵòÍö£Û16£­17£Ý¡£ÊµÑé֤ʵ£¬LCPÄܹ»ÓÐЧ¶Ô¿¹Gal£­3µÄ¿¹µòÍö×÷Ó㬳ý´ËÖ®Í⣬Æä×ÔÉíÒ²ÓµÓÐÓÕµ¼µòÍöµÄÄÜÁ¦£Û18£Ý¡£ÔÚLCPÓÕµ¼¶à·¢ÐÔ¹ÇËèÁöµòÍöµÄÊÔÑéÖУ¬µòÍöÐźű»Ö¤Ã÷ÓÉcaspase£­8 ͨ±¨ÖÁcaspase£­3(¼´ÍâÔ´ÐÔµòÍöͨ·)£¬¶ÔÏßÁ£ÌåĤµçλµÄ¸Ä±äȱ·¦×ã¹»Ö¤¾Ý£Û19£Ý¡£ÆäÓÕµ¼µòÍöµÄ¾ßÌå»úÖÆÑо¿ÉÐÔÚ½øÐÐÖС£

    7.LCP¶Ôϸ°û¶¾Ò©ÎïµÄÔöÃô¼°»¯ÁÆÒ©Îï¶Ô¿¹ºóµÄÄæת

    Ö×Áöϸ°û¶Ô¿¹Ö×ÁöÒ©Îﱬ·¢ÄÍÒ©Êǵ¼ÖÂÖ×Áö»¯ÁÆʧ°ÜµÄ³£¼ûÒòËØ£¬Ò²ÊÇÀ§ÈÅÖ×ÁöÖÎÁƵÄÒªº¦ÐÔÄÑÌâ¡£´ó¶¼»¼ÕßÔÚ¾­¹ý¿¹Ö×ÁöÒ©ÎïÖÎÁÆÓÐЧµÄһ׼ʱ¼äºó£¬·ºÆð²î±ðˮƽµÄÒ©Îï¶Ô¿¹¡£ÊµÑéÖ¤Ã÷ͨ¹ýÒÖÖÆGal£­3¿¹µòÍö¹¦Ð§£¬LCPÄÜÏÔÖøÔö¼ÓѪ¹ÜÈâÁöϸ°û¶Ô¶àÈá±ÈÐÇËùÓÕµ¼µòÍöµÄÃô¸ÐÐÔ;ÔöÇ¿¶à·¢ÐÔ¹ÇËèÁöϸ°û¶ÔµØÈûÃ×ËÉÓÕµ¼µòÍöµÄ·´Ó¦ÐÔ;Äæת¶à·¢ÐÔ¹ÇËèÁöϸ°û¶ÔÅðÌæ×ôÃ×µÄÄÍÒ©ÐÔ£Û19£­20£Ý¡£ÕâÖÖЭͬ×÷ÓÃÔÚÓ벬Àà¡¢æß¼îÀà¡¢ÅðÌæ×ôÃס¢°¢Ã¹ËØÀàµÈϸ°û¶¾Ò©ÎïÅäÏàÖúÓÃʱ¾ùÓÐÌåÏÖ£Û21£­22£Ý¡£LCPµÄÕâÖÖÌØÐÔΪÁÙ´²¿¹Ö×ÁöÖÎÁƵĸøÒ©Õ½ÂÔÌṩÁËеÄÑ¡Ôñ¡£

    8.½áÓï

    ×÷ΪҽѧÉúÎï¼¼ÊõÑо¿µÄÇ°ÑØÁìÓò£¬¿¹Ö×ÁöµÄ·Ö×Ó°ÐÏòÖÎÁÆÔÚÑо¿ÓëÓ¦ÓÃÖв»¾øÈ¡µÃÐÂÍ»ÆÆ¡£ÐµİеãºÍÕë¶Ô¸Ã °ÐµãµÄÒ©ÎïÑо¿Ô½À´Ô½Êܵ½¹Ø×¢¡£Gal£­3ÓëÖ×Áö±¬·¢¡¢Éú³¤ÃÜÇÐÏà¹Ø¡£×÷ΪÆä¸ßÇ׺ÍÁ¦ÅäÌ壬LCP¾ºÕùÐÔÒÖÖÆÌåÄÚGal £­3£¬¹Ø±ÕÆäÍâòµÄ½áºÏλµã£¬¾ßÓй㷺µÄ¿¹Ö×ÁöÌØÐÔ¡£Ç°ÆÚµÄÌåÍâÓëÌåÄÚʵÑéΪ½øÒ»²½Ñо¿´òÏÂÁ˼áʵµÄ»ù´¡¡£ËäÈ» LCPµÄijЩ¿¹Ö×Áö×÷ÓõľßÌå»úÖÆÉÐδÃ÷È·£¬µ«ËüÒѾ­ÏÔʾ³öÁÙ´²Ó¦ÓõĿÉÐÐÐԺͽϴóµÄDZÁ¦¡£Óë´Ëͬʱ£¬ÎÒÃÇÒ²Çå³þ µØÈÏʶµ½£¬½«LCPÍÆÏòÁÙ´²¿¹Ö×ÁöÖÎÁƵÄÒ»Ïߣ¬ÁíÓнϳ¤µÄ·Ҫ×ß:ÖîÈçÔÚ²î±ðµÄÖ×ÁöÖУ¬Gal£­3µÄ±í´ï²î±ðºÜ´ó£¬LCP ×÷ΪÒÀÀµÇ°Õß±í´ï¶ø±¬·¢×÷ÓõÄÒ©ÎÊÇ·ñÄܹ»Îȶ¨ÌåÏÖ³öÓÐЧµÄ¿¹°©Ð§Ó¦ÉÐÐèÖ¤Ã÷¡£Ö×ÁöÉúÎïѧÐÐΪµÄÅÓ´óÐÔºÍϸ°û¿Ë¡µÄ²»¾ùÒ»ÐÔ£¬½«ÓпÉÄÜÏÞÖÆÆäÔÚÁÙ´²µÄ¹ã·ºÓ¦Óá£

    ²Î¿¼ÎÄÏ×

    £Û1£Ý VLADISLAV V£¬GLINSKY£¬RAZ A£® Modified citrus pectin anti £­metastatic properties: one bullet£¬multiple targets£ÛJ£Ý£® Carbohydrate Res£¬2009£¬344( 14) : 1788 £­ 1791£®
    £Û2£Ý NANGIA MAKKER P£¬NAKAHARA S£¬HOGAN V£¬et al£® Galectin £­ 3 in apoptosis£¬a novel therapeutic target£ÛJ£Ý£® J Bioenerg Biomembr£¬2007£¬39( 1) : 79 £­ 84£®
    £Û3£Ý ZHAO Q£¬BARCLAY M£¬HILKENS J£¬et al£® Interaction between circulating galectin £­ 3 and cancer £­ associated MUC1 enhancestumour cell homotypic aggregation and prevents anoikis£ÛJ£Ý£® MolCancer£¬2010£¬9( 1) : 154 £­ 166£®
    £Û4£Ý HSIEH T C£¬WU J M£® Changes in cell growth£¬cyclin /kinase£¬endogenous phosphoproteins and nm23 gene expression in human
    prostatic JCA £­ 1 cells treated with modified citrus pectin£ÛJ£Ý£® Biochem Mol Biol Int£¬1995£¬37( 5) : 833 £­ 841£®
    £Û5£Ý KIM H R£¬LIN H M£¬BILIRAN H£¬et al£® Cell cycle arrest and inhibition of anoikis by galectin £­ 3 in human breast epithelial cells
    £ÛJ£Ý£® Cancer Res£¬1999£¬59( 16) : 4148 £­ 4154£®
    £Û6£Ý GLINSKY V V£¬GLINSKY G V£¬GLINSKII O V£¬et al£® Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium£ÛJ£Ý£® Cancer Res£¬2003£¬63 ( 13) : 3805 £­ 3811£®
    £Û7£Ý LEHR J E£¬PIENTAKJ£® Preferential adhesion of prostate cancer
    cells to a human bone marraw endothelial cell line£ÛJ£Ý£® J Natl
    Cancer Inst£¬1998£¬90( 2) : 118 £­ 123£®
    £Û8£Ý GLINSKII O V£¬HUXLEY V H£¬GLINSKY G V£¬et al£® Mechanical entrapment is insufficient and intercellular adhesion is essential
    for metastatic cell arrest in distant organs£ÛJ£Ý£® Neoplasia£¬2005£¬7( 5) : 522 £­ 527£®
    £Û9£Ý SATHISHA U V£¬JAYARAM S£¬HARISH NAYAKA M A£¬et al£®Inhibition of galectin £­ 3 mediated cellular interactions by pectic
    polysaccharides from dietary sources£ÛJ£Ý£® Glycoconj J£¬2007£¬24( 8) : 497 £­ 507£®
    £Û10£Ý BERGMAN M£¬DJALDETTI M£¬SALMAN H£¬et al£® Effect of citrus pectin on malignant cell proliferation£ÛJ£Ý£® Biomed Pharmacothe£¬2010£¬64( 1) : 44 £­ 47£®
    £Û11£Ý THIJSSEN V L£¬HULSMANS S£¬GRIFFIOEN A W£¬et al£® The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells£ÛJ£Ý£® Am J Pathol£¬200 

     

  • ÉÏһƪ£º¸ÄÐÔ¹û½ºµÄ¿¹Ö×Áö»úÖÆÑо¿½øÕ¹
    ÏÂһƪ£ºµÍ·Ö×Ó¸ÌéÙ¹û½º¶Ô½á³¦°©Ï¸°û°ÂɳÀû²¬Ãô¸ÐÐÔµÄÓ°Ïì
  • ·µ»ØÐÂÎÅÁбí
 

    ÁªÏµ918²«ÌìÌÃ

  • µØµã£ºÕã½­Ê¡áéÖÝÊж«¸Û¾­¼Ã¿ª·¢Çø¶«¸Û4·2ºÅ
  • ÁªÏµµç»°£º0570£­8788056
  • ×ÉѯÈÈÏߣº400-7118-600
  • E-mail£ºzjgykp@163.com

Coptyright © 2018 zjgykp.com All Rights Reserved. °æȨËùÓÐ 918²«ÌìÌà  ¼¼ÊõÖ§³Ö£ºÕã½­Ö¥Â鿪ÃÅ  ÕãICP±¸19048970ºÅ-1|ºǫ́ÖÎÀí
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£º½ðÄê»á  AGÆì½¢Ìü¹ÙÍø  ÍþÁ®Ï£¶û  ÈËÉú¾ÍÊDz©  agÕæÈ˹ú¼Ê  ÀûÀ´¹ú¼Êag  ½ðÄê»á  ½ðÄê»á  Ã×ÀÖM6  ÈËÉú¾ÍÊDz«  3377ÌåÓý  AGÕæÈ˹ú¼Ê  pgµç×Ó  AGÆì½¢Ìü  Ôƶ¥¼¯ÍŹÙÍø